Risk of myocardial infarction after oophorectomy and hysterectomy

Journal of Clinical Epidemiology

Volumn 53, Issue 8, 2000, Pages 832-837

  Falkeborn, Margareta ^a   Schairer, Catherine ^b   Naessén, Tord ^c   Persson, Ingemar ^d  

^a UPPSALA UNIVERSITY   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Acute myocardial infarction; Case cohort study; Hysterectomy; Myoma; Natural menopause; Oophorectomy

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYSTERECTOMY; MENOPAUSE; OVARIECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; UTERUS MYOMA;

ADULT; COHORT STUDIES; FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOMA; MALE; MENOPAUSE; MIDDLE AGED; MYOCARDIAL INFARCTION; OVARIECTOMY; REGISTRIES; RISK FACTORS; SWEDEN; UTERINE NEOPLASMS; WOMEN'S HEALTH;

EID: 0033855684     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00187-6     Document Type: Article

References (25)

1. Gordon T., Kannel W.B., Hjortland M.C., McNamara P.M. Menopause and coronary heart disease. The Framingham study. Ann Int Med. 89:1978;157-161.
2. Rosenberg L., Hennekens C.H., Rosner B., Belanger C., Rothman K.J., Speizer F.E. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 139:1981;47-51.
3. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. N Engl J Med. 316:1987;1105-1110.
4. Palmer J.R., Rosenberg L., Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol. 136:1992;408-416.
5. van der Schouw Y.T., van der Graaf Y., Steyerberg E.W., Eijkemans J.C., Banga J.D. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 347:1996;714-718.
6. Lapidus L., Bengtsson C., Lindquist O. Menopausal age and the risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Obstet Gynecol Scand. suppl)130:1985;37-41.
7. La Veechia C., Decarli A., Franceschi S., Gentile A., Negri E., Parazzini F. Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age. Am J Obstet Gynecol. 157:1987;1108-1112.
8. Punnonen R., Ikäläinen M., Seppälä E. Premenopausal hysterectomy and risk of cardiovascular disease. Lancet. i:1987;1139.
9. Centerwall B.S. Premenopausal hysterectomy and cardiovascular disease. Am J Obstet Gynecol. 139:1981;58-61.
10. Witteman J.C.M., Grobbee D.E., Kok F.J., Hofman A., Valkenburg H.A. Increased risk of atherosclerosis in women after the menopause. BMJ. 298:1989;642-644.
11. Luoto R., Kaprio J., Reunanen A., Rutanen E.M. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol. 85:1995;515-522.
12. Rein M.S., Barbieri R.L., Friedman A.J. Progesterone. a critical role in the pathogenesis of uterine myomas Am J Obstet Gynecol. 172:1995;14-18.
13. Naessén T., Parker R., Persson I., Zack M., Adami H.-O. Time trends in incidence rates of first hip fracture in the Uppsala health care region, Sweden, 1965-1983. Am J Epidemiol. 130:1989;289-299.
14. Wacholder S., Boivin J.F. External comparisons with the case-cohort design. Am J Epidemiol. 126:1987;1198-1209.
15. Speroff L., Glass R.H., Kase N.G. Clinical gynecologic endocrinology and infertility. 3rd edition:1983;Williams & Wilkins, Baltimore, MD, USA.
16. Harrison-Woolrych B.M., Robinson R. Fibroid growth in response to high-dose progestogen. Fertil Steril. 64:1995;191-192.
17. Lobo R.A. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol. 75(suppl):1990;18S-25S.
18. Parazzini F., Negri E., La Vecchia C., Rabaiotti M., Luchini L., Villa A., Fedele L. Uterine myomas and smoking. Results from an Italian study. J Reprod Med. 41:1996;316-320.
19. Samadi A.R., Lee N.C., Flanders W.D., Boring J.R. 3rd, Parris E.B. Risk factors for self-reported uterine fibroids. a case-control study Am J Public Health. 86:1996;858-862.
20. Ogawa A., Kanda T., Sugihara S., Masumo H., Kobayashi I. Risk factors for myocardial infarction in cancer patients. J Med. 26:1995;221-233.
21. Johansson S., Vedin A., Wilhelmsson C. Myocardial infarction in women. Epidemiol Rev. 5:1983;67-95.
22. Falkeborn M., Persson I., Adami H.-O., Bergström R., Eaker E., Lithell H., Mohsen R., Naessén T. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol. 99:1992;821-828.
23. Bush T.L., Barrett-Connor E., Cowan L.D.et al. Cardiovascular mortality and noncontraceptive use of estrogen in women. results from the Lipid Research Clinics program follow-up study Circulation. 75:1987;1102-1109.
24. Hagstad A., Janson P.O. The epidemiology of climacteric symptoms. Acta Obstet Gynecol Scand. suppl 134:1986;59-65.
25. Oldenhave A., Jaszmann L.J.B., Everaerd W.T.A.M., Haspels A.A. Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol. 168:1993;765-771.